The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity.
Saved in:
| Title: | The myeloid SRC family kinase HCK regulates breast cancer growth by activating tumor-associated macrophage-led invasion and inhibiting cytotoxic T cell activity. |
|---|---|
| Authors: | Murrey MW; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia., Poh AR; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia., Steer JH; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia., Rinaldi C; Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, Crawley, WA, Australia., Mouchemore KA; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia., Dwyer AR; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia., Denisenko E; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Kuznetsova I; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Yeow Y; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Jones ME; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Hmon KPW; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Muirí DÓ; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Liu YY; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Lin W; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Forrest ARR; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia.; Harry Perkins Institute of Medical Research, Nedlands, WA, Australia., Ellies LG; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia., Joyce DA; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia., Ernst M; Olivia Newton-John Cancer Research Institute and School of Cancer Medicine, La Trobe University, Heidelberg, VIC, Australia., Pixley FJ; School of Biomedical Sciences, The University of Western Australia, Crawley, WA, Australia. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 18; Vol. 17, pp. 1709102. Date of Electronic Publication: 2026 Feb 18 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1709102 |
